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believe that this transsudate is fluid phase of bone marrow and
includes lipids (bone fat) from the internal volume of bones. It was
established, that bone fat contains mainly triglycerides (98%),
phospholipids (1.2%), small amount of cholesterol and high con-
tents of natural antioxidants - 2-4 mM. Using "polyethylene-metal"
friction pair friction coefficient was measured in present of some
biological fluids, including oily transsudate and bone fat. The
addition of the oily transsudate to the friction pair reduced fric-
tion coefficient 2-fold in comparison with effect of inflammatory
effusion. The most notable effect was observed with the bone fat
- friction coefficient decreases by 3.4 times. It was also revealed,
that introduction of the bone fat to synovial fluid essentially im-
proved its lubricating properties. In model experiment on the
sliding of a rabbit cartilage on a cartilage the influence of bone
fat under mechanical wear of articulate cartilage was studied.
During experiment the friction coefficient has grown from value
0.07 up to value 0.51. After the introduction of bone fat the friction
coefficient was reduced and remained at a near- normal level.
Conclusions: These results give the basis to believe about pos-
sible existence of arthro-medullary connection which participates
in the functioning of natural joints. The ligaments can play an
important role as a transport channels for the intrinsic joint lu-
bricant. Presence of antioxidant-bearing bone fat in a joint cavity
can improve considerably the sliding of the articulate cartilages,
inhibits formation of harmful reactive oxygen species and thus
promotes normal functioning of joints.
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Purpose: One of the key events in cartilage destruction in joint
diseases such as osteoarthritis is the degradation of the cartilage
collagen network. To support the development of novel therapies
for these diseases relevant preclinical models are needed to
study mechanisms of collagen degradation and synthesis. Ideally
these processes are studied in cartilage of human origin. How-
ever, due to the limited availability of human tissues, research is
often performed using for example bovine nasal cartilage and/or
isolated chondrocytes that are cultured in 3 dimensional matri-
ces. These methods are clearly useful, but would benefit from
an intermediate model that fills the gap to the human cartilage
explants. Therefore the aim of the current study was to setup
a bovine model for cytokine-induced articular cartilage degrada-
tion and characterize the model using a variety of compounds
targeting different disease mechanisms relevant to arthritis.
Methods: Full thickness articular cartilage punches ( 3.5 mm)
from the metacarpophalangeal joints of ± 6 months old calves
were cultured for 3 weeks in 96-well plates in the presence
P151 – Table 1 (#P < 0.05 versus unstimulated control explants; *P < 0.05 versus stimulated explants)
IL-1α Test compound % of initial Water content Denatured collagen GAG release Hyp release CTX-II release MMP activity COMP release
TNFα OSM wet weight % % % % % RFU/sec %
– – 115 76 11 35 1 5 0.9 48
+ – 91# 83# 17 82# 17# 89# 34# 74
+ Diclofenac 86 83 23 89 – 138 19 58
+ Dexamethasone 95 79* 11 91 – 5* 1.7* 63
+ Pioglitazon 87 83 27* 87 – 12* 12 97
+ Remicade 87 83 22 85 – 52 23 50
+ Risedronate 85 84 32* 84 – 95 23 48
+ Galardin 96 80* 12 90 – 5* 1.3* 43
+ A77-1726 94 79* 12 54* – 5* 1.7* 61
+ Kineret 103 78* 9* 51* – 5* 1.6* 31
or absence of a cytokine cocktail consisting of 10 ng/ml IL-
1α, 10 ng/ml TNFα and 10 ng/ml OSM. Culture medium was
refreshed weekly. After three weeks the cartilage and culture
medium were analyzed for weight changes, water content, DNA
content, glycosaminoglycans (GAG), hydroxyproline (Hyp), dam-
aged collagen molecules, MMP activity, C-telopeptide fragments
of Type II collagen (CTX-II) and cartilage oligomeric matrix pro-
tein (COMP). Diclofenac (10μM), Dexamethasone (0.5μM), Pi-
oglitazone (1μM), Remicade (10μg/ml), Risedronate (100μM),
Galardin (10μM) and A77-1726 (active metabolite of Lefluno-
mide; 100μM) were tested for their effect on cartilage degra-
dation. The experiment was performed on cartilage from three
different donors and with each test condition cultured in eight-fold
for each donor.
Results: Stimulation of the cartilage explants with a cytokine
cocktail resulted in changes that are also seen in human OA.
The weight of the explants was decreased compared to untreated
controls (24%, p < 0.01). Degradation of proteoglycans was
significantly increased by the cytokine treatment (47%, p < 0.01)
and could already be observed within 1 week after initiation of
the study. Collagen degradation (measured as Hyp and CTX-
II) was also significantly elevated, but this was seen only after
three weeks of culture. The collagen release was accompanied
by an increase in the amount of denatured collagen molecules
within the tissue (17% versus 11% in control cartilage; NS).
In accordance with the increased collagen damage, the water
content of the tissue was also increased (from 76% to 83%,
p < 0.01) which correlated with the collagen damage as well
(r = 0.88, P < 0.01). The level of active MMPs increased 40-fold
upon stimulation and correlated well with the collagen damage
(r = 0.99, P < 0.01). COMP release during the first week
of culture showed a trend towards up regulation during the
first week of culture for all three donors, this was however not
significant. A series of test compound was used to characterize
the response of the model to intervention, see table for details.
Conclusions: Stimulation of bovine articular cartilage explants
with a cocktail of IL-1α, TNFα and OSM results in clear and con-
sistent changes in the cartilage, highly reminiscent of cartilage
destruction during arthritis. The processes can be modulated by
one or more of the compounds tested, indicating that this model
for articular cartilage destruction is sensitive to treatment.
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Purpose: Chondroitin sulphate (CS) is a complex carbohydrate
polymer with variable sulphation which impacts function. Shark
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CS may have GalNAc 4-O- or 6-O- sulphation and additionally
GlcA 2-O-sulphation. CS from trachea is mainly GalNAc 4-O-
sulphated while that from load bearing cartilages have higher
levels of 6-O-sulphation.CS is widely used by those suffering os-
teoarthritis and a deeper understanding of CS structure/function
relationships. However, available tools permit acquisition of com-
positional, but not sequence data, from CS, and it is likely that CS
functional motifs will be embedded within domains of sequence.
Methods: We have used novel chondroitin C lyase depolymeri-
sation methods allied with HPLC and novel Mass Spectrometry
(MS) methods of oligosaccharide analysis to study CS compo-
sition and sequence. In addition intact CS chain structure has
been studied by NMR spectroscopy.
Results: We have demonstrated that CS sulphation is non-
random, that CS sulphation occurs in domains and that there are
differences in CS composition and sequence between species.
Data from shark cartilage show that GalNAc 4-O- and 6-O-
sulphation occurs in blocks showing the domains of structure
within a non-random CS chain. Shark CS contains 2-O-sulphated
residues which are mostly found between residues with 4-O- and
6-O-sulphation in agreement with studies of the sulphotrans-
ferase activity. The 2-O-sulphation level increases with length,
suggesting a preferential localisation towards the non-reducing
end of the chain. Examination of tracheal CS from a range of
mammals (e.g. human, bovine, porcine and ovine) shows that
the composition and sequence of each differs. Further, we show
that the CS from non-mammalian species e.g. chicken, is also
unique. Many of these are used as sources of commercial CS
and we therefore demonstrate that choice of species used to
derive CS dictates the structure of the product. The level of 4-
sulphation in bovine tracheal CS (ca. 70%) is significantly lower
than that found in chicken CS (ca. 80%) and while the distribu-
tion of 4-sulphates throughout chicken CS is relatively uniform,
this is not the case for bovine tracheal CS in which longer
chains contain more 4-sulphated residues. These differences in
composition and sequence will significantly change the profile
of the CS and hence functionality. We have isolated defined
CS oligosaccharides of up to 20-mer and demonstrated both
purity and structure by NMR spectroscopy. These represent the
largest pure defined oligo-saccharides isolated to-date and they
represent a significant resource for further studies.
Conclusions: We have shown that digestion of CS with chon-
droitin C lyase allows the abundance of blocks of 4-O-sulphated
GalNAc residues to be determined in an analytical method, suit-
able for acquiring sequence related data from CS chains to
increase our understanding above that available from composi-
tional analysis. CS structure impacts interactions and it will be
important to use these techniques to characterise binding sites
for protein binding partners. The localisation of sulphation was
confirmed to be non random in local requirements and in the
abundance along the chain length. These data also confirm that
MS methods are appropriate for acquiring quantitative data on
CS oligosaccharide abundance from heterogeneous mixtures.
We also show that NMR spectroscopy can be used to acquire
detailed structural data from intact CS chains.
These data show that the source tissue used for CS preparation
can have a significant impact upon the composition, sequence
and hence functionality of the material isolated.
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Purpose: The trefoil factor family peptide 3 (TFF3, also known
as intestinal trefoil factor) has been implicated in epithelial tissue
restoration and is found associated mainly with mucosal epithelial
surfaces. In the present investigation we addressed the question
whether TFF3 has also a role in articular cartilage restoration.
Methods: Healthy and osteoarthritic human articular cartilage
samples were compared with regard to expression and pro-
duction of TFF3 by means of RT-PCR, Western-blotting and
immunohistochemistry. TFF3 production in cultures of human
primary chondrocytes as well as T/C-28a2 chondrocytes after
incubation with tumor necrosis factor a (TNFa) and interleukin-1
(IL-1) was determined by immunostaining on glass cover slides
and immunodot blot. Immunohistochemical analyses were per-
formed to study the expression of Tff3 in osteoarthritic cartilage
of STR/Ort mice.
Results: We found mRNA expression of human TFF3 in both
human healthy and osteoarthritic cartilage, whereas production
on the protein level was only visible in osteoarthritic cartilage.
In the early stage of osteoarthritis (OA) TFF3 was detected
in the cytoplasm and in the extracellular matrix while in late
stages only intracellular immunostaining was observed. TNFa
and IL-1-treated primary chondrocytes stained clearly with TFF3
antibody, whereas untreated cells were negative. Some T/C-
28a2 cells revealed positive TFF3-staining without pretreatment.
After TNFa administration the staining was increased; IL-1 had
no effect. Immunodot blot analysis of culture supernatants from
primary chondrocytes supported the finding of increased TFF3
secretion after administration of TNFa and IL-1. STR/Ort mice,
which are genetically predisposed to develop OA-like lesions in
the knee joint, demonstrated positive TFF3-staining of some but
not all chondrocytes especially in early stages of OA.
Conclusions: These findings suggest a possible protective role
of human TFF3 during OA, due to a possible control of matrix
degrading enzymes (MMPs) or apoptosis, and encourage further
investigations.
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Purpose: Osteoarthritis (OA) and rheumatoid arthritis (RA) are
characterized by high expression of the proinflammatory cy-
tokines interleukin-1β (IL-1β), and tumour necrosis factor alpha
(TNF-α). Several studies have reported the involvement of the
Notch signaling pathway in the patophysiology of RA. Several
studies have shown that stimulation of synoviocytes from pa-
tients with RA with TNF-α induces expression of Notch1, 4, and
Jagged2 as well as nuclear translocation of the intracellular do-
